|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
TNO Quality of Life Laboratoire Oenobiol |
|---|---|
| Information provided by: | TNO Quality of Life |
| ClinicalTrials.gov Identifier: | NCT00328913 |
Purpose
The aim of the study is to show evidence of the efficacy of 5-HTP to induce satiety and to reduce food intake (confirmatory study).
The primary objective of the present study is to determine:
The secondary objectives of the present study are to determine the effectiveness of a 5-HTP preparation on:
| Condition | Intervention | Phase |
|---|---|---|
|
Obesity |
Drug: 5-hydroxytryptophan (food supplement) |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study |
| Official Title: | Effectiveness of 5-Hydroxytryptophan on Satiety in a Randomised, Placebo Controlled, Time Blinded Study, in Overweight Women |
| Estimated Enrollment: | 24 |
| Study Start Date: | March 2006 |
| Estimated Study Completion Date: | July 2006 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Healthy as assessed by:
Exclusion Criteria:
Subjects with one or more of the following characteristics will be excluded from participation:
Contacts and Locations| Netherlands, Utrecht | |
| TNO Quality of Life | |
| Zeist, Utrecht, Netherlands, 3704HE | |
| Principal Investigator: | Wilrike Pasman, PhD | TNO Quality of Life |
More Information
| Study ID Numbers: | P6880 |
| Study First Received: | May 22, 2006 |
| Last Updated: | January 8, 2007 |
| ClinicalTrials.gov Identifier: | NCT00328913 History of Changes |
| Health Authority: | Netherlands: Medical Ethics Review Committee (METC) |
|
satiety food intake mood wellness |
weight management satiety food intake |
|
Body Weight Signs and Symptoms Obesity Psychotropic Drugs 5-Hydroxytryptophan |
Nutrition Disorders Overnutrition Overweight Antidepressive Agents, Second-Generation Antidepressive Agents |
|
Obesity Psychotropic Drugs Overweight Pharmacologic Actions Body Weight Signs and Symptoms Therapeutic Uses |
5-Hydroxytryptophan Nutrition Disorders Overnutrition Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |